Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass

Obesity Surgery

Volumn 15, Issue 10, 2005, Pages 1384-1388

  Sanchez, Barry R ^b   Morton, John M ^a   Curet, Myriam J ^b   Alami, Ramzi S ^b   Safadi, Bassem Y ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Gastrointestinal stromal tumor; Laparoscopy; Morbid obesity; Roux en Y gastric bypass

Indexed keywords

BYPASS SURGERY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; MITOSIS; NECROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; FEMALE; GASTRIC BYPASS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENTAL FINDINGS; LAPAROSCOPY; MALE; OBESITY, MORBID;

EID: 28544442149     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089205774859326     Document Type: Review

References (18)

1. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075-9.
2. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100: 162-68.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20.
4. Roggen JF, Velthuysen MF, Hogendoorn PW. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001; 54: 96-103.
5. Pidhorecky I, Cheney RT, Kraybill WG et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7: 705-12.
6. Mochizuki Y, Kodera Y, Ito S et al. Treatment and risk factors for recurrence after curative resection of gastrointestinal stromal tumors of the stomach. World J Surg 2004; 28: 870-5.
7. Savage DG, Antman KH. Imatinib mesylate - a new oral targeted therapy. N Engl J Med 2002; 346: 683-93.
8. Miettinen M, El-Rifai W, Sobin L et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002; 33: 478-83.
9. Kim HC, Lee JM, Kim KW et al. Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy. AJR 2004; 183: 893-8.
10. Wu PC, Langerman A, Ryan CW et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003; 134: 656-66.
11. Pierie JP, Choudry U, Muzikansky A et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001; 136: 383-9.
12. Matthews BD, Walsh RM, Kercher KW et al. Laparoscopic vs. open resection of gastric stromal tumors. Surg Endosc 2002; 16: 803-7.
13. Röthlin M, Schöb O. Laparoscopic wedge resection for benign gastric tumors. Surg Endosc 2001; 15: 893-5.
14. Singer S, Rubin BP, Lux ML et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002; 20: 3898-905.
15. Dematteo RP, Heinrich MC, El-Rifai WM et al. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 2002; 33: 466-77.
16. Aparicio T, Boige V, Sabourin JC et al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. EJSO 2004; 30: 1098-103.
17. Nilsson B, Bumming P, Mels-Kindblom JM et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. Cancer 2005; 103: 821-9.
18. Ajduk M, Mikulic D, Sebecic B et al. Spontaneously ruptured gastrointestinal stromal tumor (GIST) of the jejunum mimicking acute appendicitis. Coll Antropol 2004; 28: 937-41.